IL-23/IL-17 axis is an important regulator in various inflammatory diseases. However, the role of IL-23 in allergic airway inflammation is not well understood. In this study, we show that in an ...
To determine the impact of IL-23 knockdown by RNA interference on the development and severity of ovalbumin (OVA)-induced asthmatic inflammation, and the potential mechanisms in mice, the ...
Selective interleukin-23 (IL-23) inhibitors for the management of psoriasis are administered every 8 to 12 weeks, compared with previous treatment options that required a weekly, biweekly, or monthly ...
NEWARK, Calif., Oct. 29, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (NASDAQ:PTGX) today announced that two additional oral peptide IL-23 receptor antagonist candidates from its collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results